ViewRay Inc. closed a public offering of common shares, raising about $149.6 million in gross proceeds.
The medical-device maker sold 47,782,500 shares at $3.13 apiece. This includes 6,232,500 additional shares sold as part of the underwriters' full exercise of the overallotment option.
Net proceeds will go toward capital expenses plus funding for research and development, investments, commercial activities, clinical data generation and infrastructure.
Elekta AB (publ) and Medtronic PLC participated in the offering, completing their respective investment agreements, ViewRay said.
Piper Jaffray & Co. was the lead book runner while Guggenheim Securities LLC acted as a book runner, and Oppenheimer & Co. Inc. acted as the co-manager for the offering.
Oakwood, Ohio-based ViewRay designs and manufactures radiation therapy systems for use in imaging and treating cancer patients.